Logo-bi
Bioimpacts. 2024;14(2): 27829. doi: 10.34172/bi.2023.27829
PMID: 38505675        PMCID: PMC10945302

Original Article

Introduction of a new recombinant vaccine based on GRP78 for breast cancer immunotherapy and evaluation in a mouse model

Hamed Zare 1 ORCID, Hamid Bakherad 2,3 * ORCID, Arman Nasr Esfahani 2, Mohamad Norouzi 2, Hossein Aghamollaei 4, Seyed Latif Mousavi Gargari 5, Fatemeh Mahmoodi 6, Mahdi Aliomrani 7, Walead Ebrahimizadeh 8

Cited by CrossRef: 2


1- Herrera-Quintana L, Vázquez-Lorente H, Plaza-Diaz J. Breast Cancer: Extracellular Matrix and Microbiome Interactions. IJMS. 2024;25(13):7226 [Crossref]
2- Bhamidipati P, Nagaraju G, Malla R. Immunoglobulin-binding protein and Toll-like receptors in immune landscape of breast cancer. Life Sciences. 2024;358:123196 [Crossref]


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge